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a b s t r a c t   
 
Background: Universal health care (UHC) should ensure equal access to and use of surgery, but few studies 
have explored variation in UHC systems. The objective was to describe practice of distal pancreatectomy 
in Norway covered exclusively by an UHC. 
Methods: Data on all patients undergoing distal pancreatectomy from the Norwegian Patient Register over 
a 5-year period. Age- and gender-adjusted population-based resection rates (adj. per million/yr) for distal 
pancreatectomy were analysed across 4 regions and outcomes related to splenic salvage rate, hospital 
stay, reoperation, readmissions and 90-day mortality risk between regions. Risk is reported as odds ratio 
(OR) with 95% confidence interval (c.i.). 
Results: Regional difference exist in terms of absolute numbers, with  the majority of procedures done  in  one 
region (n ¼ 331; 59.7%). Regional variation persisted for age- and gender-adjusted  population-rates, with 
highest rate at 23.8/million/yr and lowest rate at 13.5/mill/yr (for a 176% relative difference; or an absolute 
difference of þ10.3 resections/million/yr). Overall, a lapDP instead of an open DP was 3.5 times more likely 
in SouthEast compared to all other regions combined (lapDP rate:  83%  vrs 24%, respectively; OR 15.4, 95% 
c.i. 10.1e23.5; P < 0.001). The splenic salvage rate was lower in SouthEast (19.9%) compared     to all other 
regions (average 26.5%; highest in Central-region at 37.0%; P ¼ 0.010 for trend). Controlled for other factors in 
multivariate regression, ‘region’ of surgery remained significantly associated with laparoscopic access. 
Conclusion: Despite a universal health care system, considerable variation exists in resection rates, use of 







The use of common surgical procedures can vary considerably 
across regions [1]. Even within countries having universal health 
care (UHC) coverage and similar access to care, the regional varia- 
tion in provision of certain procedures, use of certain techniques (e.g. 
minimal invasive surgery) or surgical care can vary consider- ably 
[2,3]. In Scandinavia, variation in both the use of laparoscopic 
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access and surgical care for gastrointestinal disease has been 
demonstrated [2e4]. 
A laparoscopic approach is increasingly advocated for resection 
of lesions in the distal pancreas with studies pointing to favourable 
short-term outcomes [5]. However, in studies reporting nationwide 
data, use of laparoscopic resections vary from 12% as reported in 
France [6] to 59% in Norway [7]. However, regional variation may 
exist within a country based on both catchment area, surgical 
volumes, hospital and surgeon practices but has not been investi- 
gated in detail. 
In general, variation in surgical practice is largely described as or, 
believed to be, a result of differences in illness burden (e.g. variation 




diagnostic practices (e.g. threshold for use of imaging studies in the 
population) and variation in patients' attitudes towards interven- 
tion. However, data suggest that this can only explain a small de- 
gree of regional variation in surgery rates [1]. Evidence 
demonstrates that surgical variation results mainly from differ- ences 
in physician beliefs about the indications for surgery and the extent 
to which patient preferences are incorporated into treat- ment 
decisions. These two components of clinical decision-making help to 
explain the so-called ‘surgical signatures’ of specific pro- cedures, 
and why some consistently vary more than others. 
We have previously shown that there was little variation in the 
population-based resections rates for pancreatoduodenectomy 
(Whipples procedure) across four health regions in Norway [8]. 
Notably, pancreatoduodenectomy is exclusively performed as open 
surgery in Norway and predominantly for malignant/premalignant 
conditions according to national guidelines. As a complex and high- 
risk procedure, the practice of pancreatoduodenectomy may be less 
prone to variation within a regulated system, compared to that of 
distal pancreatic resection. Variation in the practice of laparoscopic 
distal pancreatic resection is still evident with considerable differ- 
ences in opinions, attitudes as well as experience in laparoscopy 
across the globe [9]. 
In Norway, the universal health care system allows for regis- 
tration of all hospital-based procedures and hospital admissions that 
can be matched to a select number of valid and robust out- comes 
across all hospitals. In the ongoing process of adopting new 
techniques into routine practice in pancreatic surgery, an overall 
monitoring of procedural implementation and use across a health 
care system and their associated outcomes is highly warranted. 
Thus, the aim of this study was to investigate the regional 
variation in use of distal pancreatectomy in a UHC system where 
fee-for-service and insurance coverage does not impact on surgical 
practice. 
 




This was a longitudinal, observational national 5-year cohort 
study covering the universal health care system in Norway (from 
1.1.2012 to 31.12.2016), as described in detail previously for 
nationwide data and time-trends [7,8,10] and consulting the 
guidelines for Strengthening the Reporting of Observational Studies 




Centre of Clinical Documentation and Evaluation (SDKE, 
Northern Norway Regional Health Authority; Tromsø, Norway) 
holds a concession from the Norwegian Data Protection Authority 
to access data from the Norwegian Patient Registry (NPR). The 
Norwegian Data Inspectorate licensed the data registry at Centre for 
Clinical Documentation and Evaluation (ref. 15/00271e2/CGN and 
16/00289e2/CGN). The study design is based on clinical 
administrative data and thus non-experimental in design. Further 
ethical approval or obtaining informed consent was not required 
according to Norwegian law for this study. 
 
Data from the Norwegian Patient Registry (NPR) 
 
The details of the inclusion and exclusion criteria have been 
presented previously [7,10]. Briefly, all Norwegian hospitals must 
submit data to the Norwegian Patient Registry (NPR) for registry 
and reimbursement purposes. The selected NPR variables have 
good data quality and high completeness [12]. A more detailed 
description of data capture and coding retrieval have been described 
previously [10], and reported for pan- creatoduodenectomy [8] and 
distal pancreatic resections [7] in a nationwide perspective. 
Operations were identified from the Nordic Medico-Statistical 
Committee (NOMESCO) Classification of Surgical Procedures 
(NCSP), version 2014 [13], with codes for open (JLC10) and 
laparoscopic (JLC11) distal pancreatectomy with or without 
inclusion of splenectomy code (open or laparoscopic; JMA10 or 
JMA11). Codes used for simple ‘laparoscopy’ or ‘explor- ative 
laparoscopy’, e.g. for staging procedures (JAH01 or JAH21) were not 
considered as a laparoscopic resection unless accompa- nied by a 
resectional code for laparoscopy. Thus, only the actual resectional 
codes (JLC10 and JLC11) where used to define the ‘open’ or 
‘laparoscopic’ approach. 
 
Norwegian health care system and regional autonomy 
 
Norway has a universal health care program for all citizens that 
ensure equal access to care [14]. Each of the four regional health 
authorities (RHA; Fig. 1) governs the medical and surgical care 
through several health trusts in several counties and municipal- ities, 
with both several district hospitals and some university hos- pitals 
in each region. In Norway, all surgical resections for malignant or 
premalignant lesions within the abdomen are per- formed in public 
hospitals. Encrypted patient serial numbers make it possible to 
describe patient pathways involving all hospitals across health trusts 
and over several years. Only 5 hospitals per- formed HPB surgery 
across the 4 health regions during the study period (Fig. 1). Analyses 
are done for variations between each re- gion. As the SouthEast 
region represents the largest population (about half the patients in 
the cohort) and has had a long-standing 
interest in  laparoscopic  pancreatic  surgery  [15e17],  analysis were 
also done for differences between the SouthEast region and the other 
regions combined. 
 
Population-based resection rates 
 
The population data for Norway and for each RHA catchment 
area (Fig. 1) are derived from Norway Statistics (www.ssb.no) at the 
time of study period. Adjusted resection rates for the population of 
each RHA was done based on population demographics available 
from Statistics Norway [18] and using the index year of 2015 for 
age- and gender-adjustments for the study period (Fig. 1). 
Population-based resection rates (per 1.000.000 inhabitants) were 
calculated for all distal resections and separately for open and 
laparoscopic procedures for the study period. 
 
Patient identifier and registry data 
 
All Norwegian citizens have a unique 11-digit personal identifier 
that allows tracking between hospitals, regions and registries, 
when given appropriate concession under data-protection regula- 
tions (e.g. such as the current concession held by NPR). Notably, 
hospital stay is possible to monitor after discharge across health 
trusts and other hospitals by coupling the unique patient identifier 
with any subsequent stay at any Norwegian hospital with an 
admission date within 30 days from the index procedure. Hospital 
stay was reported as described in detail previously [10] using as an 
aggregated length of stay (aLoS). An aLoS was counted as the total 
(cumulative) number of nights spent in any hospital within the first 
30 days from an index operation; index stay, pluss any transfer or 
readmissions within the same 30-day period. In order to explore 
any differences in rates of a long (>1 week) or very long (>2 weeks) 








Fig. 1. Description of the regional health regions and catchment population. 
Legend: There are 5 centres in Norway doing hepatobiliary and pancreatic (HPB) surgery during the study period across the regional health authorities (RHA): one in the North 
(University Hospital of Northern-Norway), one in Central (St. Olav's Hospital) Regional Health Authority region and two in the West (Haukeland University Hospital; and, Stavanger 
University Hospital) and one in SouthEast (Oslo University Hospital at Rikshospitalet). Population demographics are presented from Norway statistics (www.ssb.no); the population 




As described previously [7], grouping of patients into  di-  agnostics 
groups was done on a pragmatic  basis.  Thus,  patients  were designated 
to one of three disease groups, as used  by others  [19], reflecting the 
underlying  disease  or  indication  for  surgery based on the coding 
provided from ICD-10 codes,  as  ‘Malignant’  (e.g. C25 codes), 
‘Premalignant/cysts’ (e.g. D37 codes or K86.2) or ‘Benign, other’ (e.g. 
D13.6 or D13.7 codes),  as  described  previously [7]. 
Surgical access was assigned based on the designated code for 
‘laparoscopic’ or ‘open’ resection in the register. Notably, coding for 
converted cases does not exists and are thus not accounted for. The 
designated category assumes that the actual coding reflects the 
predominant part of the procedure, if converted (e.g. early con- 
version is likely to be coded as open; late conversions may have been 
coded as laparoscopic). 
Splenic salvage is defined as any distal pancreatectomy done 
without concurrent splenectomy (i.e. without a code for open 
‘JMA10’ or laparoscopic splenectomy ‘JMA11’) and reported as a rate 
for all procedures (e.g. % done without concomitant splenectomy) 
and separately for open and laparoscopic procedures. 
Multivisceral resections were defined as any distal pancreatec- 
tomy (±splenectomy) that also included an additional resectional 
procedure, such as resection of stomach, colon, or adrenals/kidney. 
Comorbidity was described by the Charlson Comorbidity Index (CCI) 
[20] using the methods described by Quan et al. [21] for administrative 
data and Charlson Age-adjusted Comorbidity Index (CACI) for which 
each decade over 40 is given one added point to the CCI score [22]. A 
value for CCI 2 and CACI 6 were considered 
as ‘high comorbidity’ for the current study. 
 
Assessment of outcomes between regions 
 
For each RHA, the previously described short-term outcomes for 
evaluation included hospital stay (the accumulated days spent in 
hospital, including index hospital stay any transfer stay any 
readmissions: reported as ‘aggregated length of stay’, or aLOS) [7]. 
Furthermore, reoperations, readmissions and mortality at 90 days 




Data were analysed using SAS 9.4 (SAS Institute, Cary NC) and 
Statistical Package for Social Sciences (IBM© SPSS© for Mac, v. 25). 
Descriptive analyses are presented as medians or as rates (%) and, 
where applicable, analysed by non-parametric tests for continuous 
variables or by Chi-square or Fischer's exact test for rates. Chi- 
square with four degrees of freedom was used to test for trend in 
variation between all the four RHAs and presented as Ptrend. Ana- 
lyses of between regions were further dichotomized into ‘South- 
East’ vrs ‘all others’. Risk analyses was presented for regions 
dichotomized to South-East vs all others and presented as odds 
ratio (OR) with 95% confidence intervals (95% c.i.). Multivariable 
analysis was done using binominal regression (Forward Wald). All 





A total of 554 resections were included (Fig. 2), showing dis- 





Patients’ distribution of age, gender and comorbidity between 
regions are presented in Table 1 and Fig. 3. A significant difference 
in trend  between  age-groups  was  present  between  regions  (Ptrend 
0.049; Fig. 3), related to differences in the middle  aged (65e74 years) 
and oldest (>75 yrs) groups of patients. The differ- ence persisted 













Fig. 2. Flowchart of study population and laparoscopic rate in each RHA 
Legend:*Excluded were distal pancreatectomies not done as a primary pancreatic resection (e.g. as part of a resection for gastric cancer or a colonic splenic flexure cancer). Thus, any 
case with a pancreas resection code coupled with codes representing another disease (e.g. colon resection with diagnostic ICD-10 code of colon cancer, e.g. C18.x) were excluded. 
Codes of distal pancreas resection with a trauma diagnosis (S.x codes) were excluded. Cases with missing dates for hospital stay were also excluded. 
Ptrend <0.001 for differences in laparoscopy rate between the regions. 
 
lower rate of elderly patients operated in the SouthEast (14% vs 
22%; P 0.008). No difference in the number of patients with high 
comorbidity was found between regions when comparing all DPs. 
However, when stratified for laparoscopy as the procedure, there 
were significantly more men in the SouthEast (54% vs 38% in all  
other;  OR  1.4,  95%  c.i.  1.0e2.1;  P     0.026), fewer elderly 75 
years (15% in SouthEast vs 21% in all others; P 0.046), fewer pa- 
tients with high comorbidity (SouthEast 9% vs 19% for all others; OR 
2.3, 95% c.i. 1.0e5.2; P 0.036) and fewer patients had  splenic 
salvage in SouthEast  (21%  vs  51%  for all  others;  OR  1.6,  95% c.i. 
1.2e2.1;  P < 0.001)  compared to all  other  regions. Such differences 
were not found for the open DP groups when comparing between 
dichotomized regions, except for a higher rate of CCI>2 in the open 
category for SouthEast compared to all others (30% vs 17%; OR 1.7, 




Distribution of patient characteristics between health regions. 
 
 South East West Central North Ptrend 
N 331 108 81 34  
Women, n (%) 160 (48%) 67 (62%) 41 (51%) 16 (47%) 0.093 
CCI 





















Diagnostic gr.     0.740 
Malignant 193 (58.3%)    63 (58.3%)    48 (59.3%)    16 (47.1%) 
Premalignant    121 (36.3%)    38 (35.2%)    29 (35.8%)    14  (41.2%) 
Benign 17 (5.1%) 7 (6.5%) 4 (4.9%) 4 (11.8%) 
 
 
CCI denotes Charlson Comorbidity Index. 
CACI denotes Charlson Age-Comorbidity Index. 
Population-based resection rates and use of laparoscopy 
 
There was a significant difference in laparoscopy rate between 
the four RHA with SouthEast (83%) standing out with a much higher 
rate than all other regions (lowest RHA West 15%), or an OR of 15.4 
(95% c.i. 10.1e23.5; P < 0.001) when comparing to all other regions 
combined. Both the absolute number and the relative rate of lap- 
aroscopy varied considerably between the health regions (Fig. 4). 
Considerable regional difference across Norway were found in 
terms of absolute highest and lowest numbers (SouthEast n 331, 
59.7%) and North (n 34, 6.1%, respectively; a 10-fold difference). The 
population-adjusted resection rates for all distal pancreatec- 
tomies per RHA is presented in Fig. 4. The differences  in  overall, open 
and laparoscopic rates persisted when adjusted  per  popula-  tion 
(23.8/million/yr vs 13.5/mill/yr; 176% relative difference) with  an 
absolute difference of 10.3 resections/million/yr between  the region 
with highest and lowest resection-rate. Overall, having  a  lapDP rather 
than an open DP was over 3.5 times more likely in SouthEast compared 
to all other regions (82.8% vs. 23.5% LDPs, respectively; OR 15.4, 95% 
c.i. 10.1e23.5; P < 0.001). 
 
Regional variation in surgery and outcomes 
 
Surgical variation in resection, including splenic salvage rate and 
multivisceral resections are presented in Table 2. The splenic salvage 
rate was slightly lower in SouthEast (19.9%) compared to the other 
regions (average 26.5%; highest in Central-region at 37.0%; Fig. 5). 
Overall, a laparoscopic approach was significantly associated with 
splenic-salvage  (Fig.  5;  OR  1.6,  95%  c.i.  1.0e2.4; P 0.035). However, 
this remained only significant for the ‘other regions’ and not 
SouthEast, for an overall splenic salvage rate of 26.5% in the ‘others 
regions’. The open salvage rate was 18.8% (32 of 






Fig. 3. Distribution of patients' age-groups between regions. 




Fig. 4. Population-based resection rates of distal pancreatectomy. 
Legend: Resection rates are age- and gender-adjusted over time and presented per 1000 000 inhabitants. A.) Total; B) open, C) laparoscopic. 
 
ci 2.3e8.7; P < 0.001). No such association was found for age, gender, 
comorbidity, or diagnostic groups. 
The difference between regions in aLOS >1 week (SouthEast 41% 
vs 57% for all others; OR 1.9, 95% c.i. 1.1e3.5; P 0.030) were only 
significant between regions for the laparoscopic DP group, but not 
for the open group. The difference in rates >2 weeks was only 
significant for all DPs compared between regions, but not for open 
or laparoscopy alone. 
There were no regional differences in reoperations, read- 
missions and 90-day mortality between regions. 
In multivariate regression, the factors related to use of lapDP 
when controlled for gender, age, year of procedure, comorbidity 
class, diagnostic groups, and region of surgery, only region 
remained significant predictor of having a laparoscopic approach, 
both when analysing between each of the 4 regions and when 






Distribution of distal pancreatectomy and related outcomes between regions. 
 
 South East West Central North Ptrend 
N 331 108 81 34  
Spleen salvage, n (%) 66 (19.9%) 22 (20.4%) 30 (37.0%) 7 (20.6%) 0.010 
Multivisceral 7 (2.1%) 4 (3.7%) 2 (2.5%) 3 (8.8%) 0.152 
Reoperation, n (%) 17 (5.1%) 12 (11.1%) 2 (2.5%) 3 (8.8%) 0.057 
Readmission, n (%) 67 (20.2%) 23 (21.3%) 13 (16.0%) 6 (17.6%) 0.799 
Hospital stay >7 days, n (%) 155 (46.8%) 93 (86.1%) 59 (72.8%) 21 (61.8%) <0.001 
>14 days, n (%) 62 (18.7%) 38 (35.2%) 24 (29.6%) 10 (29.4%) 0.003 




Fig. 5.   Variation in splenic salvage rates between regions. 
 
10.1e23.5; P < 0.001). 
Keeping region as a dichotomized variable in multivariable an- 
alyses and adjusting for surgical access, reoperations were signifi- 
cantly associated with diagnostic groups (P < 0.048) but no other 
variables. No significant associations were found to readmissions, 




The current study of practice of distal pancreatectomy in a UHC 
system found considerable variation across four health regions. 
Variation was evident for population-adjusted resection rates, to 
some extent for case-mix (including age-groups, gender and co- 
morbidity in subgroups), for use of laparoscopic approach, for 
splenic salvage rate, and also for length of hospital stay. No differ- 
ences between regions were found in other outcomes, including 
rates of reoperations, readmissions and 90-day mortality. 
We have previously shown that use of distal pancreatectomy is 
increasing overall in Norway, and this is related to a significant 
increase in laparoscopic procedures [7]. One should keep in mind 
that while resection rates in Norway (during the same time period) 
also increased for pancreatoduodenectomies, the difference in 
population-adjusted resection rates between regions was 
negligible for this procedure [8]. Thus, rates of pan- 
creatoduodenectomies stand in contrast to the current findings 
that demonstrate a 176% relative difference in the population- 
adjusted resection rate between the region with the lowest and 
the highest rates. In absolute numbers, an excess of 10 procedures 
per million per year is done in the SouthEast compared to the re- 
gion with lowest resection rate (North). This difference is less 
prominent compared to the two other regions with a higher total 
number of procedures, the West ( 2 excess procedures/mill/yr) 
and Central ( 0.6 excess procedures/mill/yr) regions. The variation 
in numbers may represent statistical outliers and chance due to the 
low total numbers in some regions and for some years. However, 
one may not exclude the possibility for a volume-effect (“the more 
you do, the more you do”) or a procedure selection bias (perceived 
less invasive procedure by laparoscopy, thus more likely to under- 
take the procedure), e.g. a parallel to the significant increase in 
cholecystectomies done in association with the introduction of 
laparoscopy [23e25], without a concomitant documented increase 
in the incidence of biliary disease. 
Nonetheless, the difference in use of laparoscopic approach is 
considerable, with a skewed number of laparoscopic procedures 
done in SouthEast. The high use of laparoscopic approach is 
mirrored in the reduced overall use of hospital days, with lower 
 
 
average aLOS, and fewer patients who spend longer times in hos- 
pital (>1 week or >2 weeks). However, there was no improvement 
in splenic salvage rate, readmission rate nor in reoperation rates 
compared to the other regions. Mortality was not different between 
regions, with 90d mortality only reported in the two regions doing 
most procedures, the West and the SouthEast. 
The higher resection rate in one region in Norway compared to 
the other regions in the same country, also when adjusted for age 
and gender distribution in the population, warrants further inves- 
tigation. The administrative nature of the dataset allows for 
hypothesis-generating results, which needs to be corroborated with 
other and more detailed data. However, there seems to be some 
variation in case-mix noted between regions, with fewer elderly 
patients and more men chosen for laparoscopy in the SouthEast 
region. Furthermore, those who had open surgery in the same re- 
gion had significantly higher comorbidity. The current dataset does 
not allow for investigation into explanatory factors such as histo- 
pathology, tumour size, patient obesity or previous surgery, any 
findings on pre-operative imaging and, particular outcomes from 
multidisciplinary discussions. One may perceive that a policy to- 
wards resection [26] rather than surveillance of smaller lesions, such 
as asymptomatic pancreatic neuroendocrine tumours, may 
contribute to the higher resection rates but this would need 
confirmation based on other granular data including histopathology 
confirmed diagnoses. However, it serves to be mentioned that it is 
generally believed that the vast majority of asymptomatic, small 
suspected neuroendocrine lesions may best be served with sur- 
veillance [27], as only a minority will ultimately need resection 
[26,27]. However, detailed comparison of lesion pathology would be 
needed to substantiate these assumptions in the current cohort. 
The rate of procedures done without a splenectomy was 
significantly higher in the laparoscopic DPs, but much lower than 
the salvage rate reported by others at 41e52% [28,29]. We have no 
information on the intended or unplanned splenectomy in conjunct 
with distal pancreatectomy in the current series. As the salvage rate 
is based on splenectomy being coded or not, the data may be not be 
accurate. However, as splenectomy is actively coded, the data 
presented most likely represents a minimum set of splenectomies 
done, and the splenic salvage rate may indeed be lower if codes are 
missing. However, we believe the findings to represent actual 
variation in practice between regions and the current attitude to- 
wards splenic salvage between regions. This warrants further in- 
depth investigation into reasons for variation in practice. Of note, 
SouthEast region has had a liberal approach to laparoscopic 
resection for body and tail adenocarcinoma, constituting 25% of all 
lapDP done in the period 2001e2016 [30] and these are usually done 
with splenectomy as part of the procedure. As laparoscopic DP is 
somewhat controversial for pancreatic adenocarcinoma and many 
are still awaiting the oncological outcomes from randomized 
studies, it may further reflect a clear difference in attitude towards 
resection which has not been followed in the other health regions. 
From a short-term perspective evaluating cost-benefit, quality of life 
and cosmesis, open and laparoscopic approach are comparable in the 
outcomes [31]. For oncological outcomes in distal resections with 
either open or laparoscopic access, only surrogate endpoints are 
reported so far [32]. 
Variations in other medical fields may also contribute to varia- 
tion in resections in the population. In theory, variation in the use of 
CT and MRI may lead to more incidental findings, which again may 
lead to more referrals and hence surgeries being done. Previous data 
from Norway have reported a considerable variation (60% variation) 
in use of imaging studies between the urban capitol of Oslo (in the 
SouthEast) and the more rural district in county Finnmark (in the 
North) [33]. The difference has recently been corroborated when 
investigated for musculoskeletal imaging 
studies [34] and in an audit from the Office of the Auditor General, 
finding a more than 3-fold difference in population-adjusted use of 
CT and MRI use across health trusts [35]. Thus, a higher than ex- 
pected use of cross-sectional imaging in the SouthEast may trans- 
late into a higher number of incidental lesions, leading off to a higher 
number of resections per population. Of notice, others have 
associated high-density regions of imaging to a higher use of sur- 
gery, such as found for nephrectomy in the US [36]. Notably, these 
hypotheses remain speculative for the current study, but warrants 
further investigation to gain better insight into mechanisms lead- ing 




Some limitations to use of administrative data should be 
mentioned. For one, the diagnostic categories used in this cohort is 
not accurate and may thus not be used to compare studies who 
present diagnosis as obtained by final histopathology. Notably, these 
codes and the diagnostic groups only reflect the working hypothesis 
under which patients may have been admitted, worked up, operated 
on and later discharged and may for some patients change on final 
pathology reports. However, for the purpose of this study, the 
grouping suffices to explain the surgical intent and use of surgery per 
se and surgical access modality to treat lesions in the tail of the 
pancreas. More importantly, the dataset lacks granular data on the 
specific procedures and the outcomes as well as causes for longer 
stay, readmissions or reoperations. These variables need to be 
obtained from sources of quality assurance and crosschecks with 
actual electronic patient records, and we intend to go forward with 
this by using data from the recently established national quality 
register for gastrointestinal surgery [37]. 
Norway has a population of roughly 5.4 million which is com- 
parable to other countries or states such as Denmark, Scotland, 
Ireland or the states of Minnesota or Colorado in the US. Notably, 
huge geographical variation in terms of access and travel distances 
exists between the same countries, preventing immediate com- 
parison for hospital catchment areas. However, we believe the 
findings may have generalizable and transferable interest to other 
regions with comparable systems and population sizes, albeit 
accepting both that differences in geography and health care pro- 
vision may exist. 
Thus, the findings reported herein are associations and not 
causations e they are hypothesis-generating data that warrant 
research effort into a better understanding of the reported variation 
across the four regions in Norway. As a similar variation was not 
noted for the same regions and hospitals for pancreatoduodenec- 
tomies [8], we assume that the variation lies in the practice of distal 
pancreatectomy and likely as an effect of minimal invasive access 
that may influence choice to operate over observation for some 
indications. This should be kept in mind when comparing results 
and outcomes from single-center studies. However, assumptions 





Data from the Norwegian Patient Register has been used in this 
publication. The interpretation and reporting of these data are the 
sole responsibility of the authors, and no endorsement by the 
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